Argon Medical Devices, Inc. reposted this
2025 is shaping up to be an extraordinary year for Argon Medical. We are thrilled to announce the acquisition of the SeQure® and DraKon™ microcatheters from Guerbet, a leading pharmaceutical company in France. Launched in 2018, these microcatheters are renowned for their navigation, trackability, and compatibility with therapeutic agents and embolics. The SeQure catheter, uniquely designed to create a fluid barrier that controls reflux and targets therapeutic delivery, stands out as a game-changer in interventional oncology. This acquisition is a pivotal step toward expanding our oncology portfolio beyond biopsy and drainage into therapeutic devices and accessories that help interventional oncologists fight cancer. These products strengthen our presence in interventional oncology while establishing a foothold in embolic procedures, aligning perfectly with our growth strategy. Following the acquisition, we’ve formed a dedicated project team to transfer manufacturing to our Athens facility, with some microcatheter SKUs expected to be available immediately. Joining us in this exciting journey are five talented new colleagues from Accurate Medical Therapeutics in Israel— Eran Miller, Tom Dagan, Matan Shtepel, Osnat Harbater, and Tair Shalem (Elkabetz)—who will be instrumental in this transition. Welcome to the Argon family! This acquisition, alongside the first patient enrollment in our CLEAN-PE pulmonary embolism study and growing adoption of the CLEANER Vac™ for peripheral thrombectomy, dynamically demonstrates our accelerating momentum. Read the full press release here: https://lnkd.in/g5N9tMkC The future is bright, and 2025 is just the beginning of what we can achieve together! We'll be speaking with the team about this exciting acquisition in more detail soon and sharing the highlights with you. #2025growth #ArgonAcquires #ArgonFamily #InterventionalOncology #MedicalAdvancements #OncologyInnovation #TeamArgon